Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Palisade Bio, Inc. - Common Stock
(NQ:
PALI
)
1.450
-0.120 (-7.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Palisade Bio, Inc. - Common Stock
Power Metallic (TSXV: PNPN | OTCQB: PNPNF) Eyes NYSE Uplisting as Polymetallic Discoveries Accelerate – More Stocks Inside
October 01, 2025
Via
AB Newswire
Loop Industries (NASDAQ: LOOP) Builds Global Momentum in Circular Textiles w/ Twist™ – More Stocks Inside
August 07, 2025
Via
AB Newswire
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
July 22, 2025
Via
ACCESS Newswire
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
January 11, 2023
Via
ACCESSWIRE
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
December 07, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Regains Compliance with Nasdaq Listing Requirements
December 01, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio (NASDAQ: PALI) Awarded Fast Track Designation from U.S. FDA for LB1148
November 22, 2022
Palisade Bio, Inc. (NASDAQ: PALI) is engaged as a biopharmaceutical company, which is focused on the research and development of
Via
Spotlight Growth
Palisade Bio is Granted Fast Track Designation from the U.S. Food and Drug Administration for LB1148 for Accelerated Return of Bowel Function following GI Surgery
November 22, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Appoints Herbert B. Slade, MD, FAAAAI as Chief Medical Officer
November 18, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Releases In-Depth Explanation of Scientific Approach of Lead Product Candidate LB1148 Through Animated Video
November 17, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Announces Reverse Stock Split
November 15, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Announces Executive Leadership Transition
October 11, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022
September 29, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Preventing Post-Surgical Abdominal Adhesions: Virtual Presentation on Palisade Bio's LB1148 Clinical Data; To Be Hosted & Moderated by Stonegate Capital Partners
March 14, 2022
Dallas, Texas--(Newsfile Corp. - March 14, 2022) - Stonegate Capital Partners is hosting a...
Via
Newsfile
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
